TIVC
NASDAQTivic Health Systems Inc.
Price$1.40+0.14 (+10.71%)
2026-01-222026-04-27
News · 26 weeks61-60%
2025-12-142026-06-07
Mix3190d
- SEC Filings15(48%)
- Insider6(19%)
- Market6(19%)
- Other4(13%)
Latest news
25 items- SECSEC Form S-8 filed by Tivic Health Systems Inc.S-8 - Valion Bio, Inc. (0001787740) (Filer)
- SECSEC Form S-8 filed by Tivic Health Systems Inc.S-8 - Valion Bio, Inc. (0001787740) (Filer)
- SECTivic Health Systems Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - Valion Bio, Inc. (0001787740) (Filer)
- INSIDERChief Executive Officer Handley Michael K converted options into 2,206 shares, increasing direct ownership by 25% to 11,030 units (SEC Form 4)4 - Valion Bio, Inc. (0001787740) (Issuer)
- SECSEC Form 10-Q filed by Tivic Health Systems Inc.10-Q - Valion Bio, Inc. (0001787740) (Filer)
- SECTivic Health Systems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Valion Bio, Inc. (0001787740) (Filer)
- INSIDERSEC Form 4 filed by General Counsel & SVP of Legal Lackey Melinda4 - Valion Bio, Inc. (0001787740) (Issuer)
- INSIDERSEC Form 3 filed by new insider Lackey Melinda3 - Valion Bio, Inc. (0001787740) (Issuer)
- SECTivic Health Systems Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Valion Bio, Inc. (0001787740) (Filer)
- SECSEC Form DEF 14A filed by Tivic Health Systems Inc.DEF 14A - Valion Bio, Inc. (0001787740) (Filer)
- SECTivic Health Systems Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Tivic Health Systems, Inc. (0001787740) (Filer)
- PRTivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream ModelTicker Symbol to Change from TIVC to VBIO Effective April 28, 2026; Company Advancing Entolimod™ Toward BARDA Funding and Strategic National Stockpile Procurement While Velocity Bioworks CDMO Builds Independent Revenue BaseSAN ANTONIO, April 23, 2026 /PRNewswire/ -- Tivic Health Systems, Inc. (NASDAQ:TIVC) today announced it is changing its corporate name to Valion Bio, Inc. and its Nasdaq ticker symbol from TIVC to VBIO, effective at market open on Tuesday, April 28, 2026. The CUSIP number for the company's common stock will remain unchanged. The rebrand is not merely cosmetic.
- SECSEC Form PRE 14A filed by Tivic Health Systems Inc.PRE 14A - Tivic Health Systems, Inc. (0001787740) (Filer)
- INSIDERSEC Form 4 filed by Bolton Sheryle4 - Tivic Health Systems, Inc. (0001787740) (Issuer)
- SECSEC Form EFFECT filed by Tivic Health Systems Inc.EFFECT - Tivic Health Systems, Inc. (0001787740) (Filer)
- SECSEC Form 424B3 filed by Tivic Health Systems Inc.424B3 - Tivic Health Systems, Inc. (0001787740) (Filer)
- PRTivic Health Selected to Present Entolimod™ as a Radiation Countermeasure and its Plans for an Oral Transmucosal Program to the Department of War Tech Watch Program on May 7thSAN ANTONIO, April 15, 2026 /PRNewswire/ -- Tivic Health Systems, Inc. (NASDAQ:TIVC), a clinical-stage immunotherapeutics company, today announced it has been selected to present at the U.S. Department of War's Tech Watch program on May 7, 2026. The Tech Watch initiative identifies emerging technologies with high-value defense and dual-use applications. Tivic Health will present its Entolimod™ TLR5 agonist lead drug candidate and its plans for an oral transmucosal delivery program for Entolimod™ — a delivery concept the Company believes has compelling and immediate relevance for
- SECSEC Form S-1 filed by Tivic Health Systems Inc.S-1 - Tivic Health Systems, Inc. (0001787740) (Filer)
- INSIDERSEC Form 4 filed by Valauri Christina Rizopoulos4 - Tivic Health Systems, Inc. (0001787740) (Issuer)
- PRPresenting on Emerging Growth Conference 91 Day 2 on April 2; Register to live streamMIAMI, April 01, 2026 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 91st Emerging Growth Conference on April 1 & 2, 2026. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: Questions@EmergingGrowth.com For updates, follow us on Twitter Day 1 – Presenting TodayWednesday, April 1, 2026 9:00Virtual Lobby opens.Register for the Conference. If you a
- NEWSTivic Receives Formal Request for Information from Ukrainian Ministry of Health Regarding Strategic Stockpiling of EntolimodSAN ANTONIO, TX / ACCESS Newswire / March 31, 2026 / Tivic Health Systems, Inc. (NASDAQ:TIVC), a clinical-stage immunotherapeutics company, today announced it has received a formal Request for Information (RFI) from the Ukrainian Ministry of Health. The RFI initiates the formal evaluation of Entolimod™ Tivic's late-stage Toll-like Receptor 5 (TLR5) agonist for potential inclusion in Ukraine's national strategic reserves as a countermeasure against Acute Radiation Syndrome (ARS). Additionally, the Ukrainian Ministry of Health has requested to schedule a pre-submission meeting for Entolimod™."Tivic's Entolimod, from our TLR5 platform, has catalyzed significant interest from international gover
- PRPresenting on Emerging Growth Conference 91 Day 1 on April 1; Register to live streamMIAMI, March 31, 2026 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 91st Emerging Growth Conference on April 1 & 2, 2026. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: Questions@EmergingGrowth.com For updates, follow us on Twitter Day 1 - WednesdayApril 1, 2026 9:00Virtual Lobby opens.Register for the Conference. If you already registered, go back to
- SECSEC Form 10-K filed by Tivic Health Systems Inc.10-K - Tivic Health Systems, Inc. (0001787740) (Filer)
- NEWSTivic CEO To Present at the Upcoming Emerging Growth's April 2026 Virtual ConferencePresentation will Cover Recent Corporate Milestones Including Securing Agreement with NIAIDSAN ANTONIO, TX / ACCESS Newswire / March 27, 2026 / Tivic Health® Systems, Inc. (NASDAQ:TIVC), a clinical-stage immunotherapeutics company, today announced that its newly appointed Chief Executive Officer, Michael K Handley, will deliver a corporate update at the Emerging Growth Virtual Conference taking place April 1-2, 2026.During the virtual conference, Mr. Handley will highlight key milestones, including the company's recent agreement with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to sponsor and conduct a preclinical study evaluat
- NEWSTivic Secures NIAID Non-Clinical Evaluation Agreement for Entolimod, Targeting Gastrointestinal Acute Radiation SyndromeArmed Forces Radiobiology Research Institute (AFRRI) Will Conduct the Gastrointestinal Acute Radiation Syndrome (GI-ARS) StudySAN ANTONIO, TX / ACCESS Newswire / March 26, 2026 / Tivic Health Systems Inc. (NASDAQ:TIVC), a clinical-stage immunotherapeutics company, today announced it has entered into an agreement with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to sponsor and conduct a series of preclinical studies evaluating Entolimod™ for gastrointestinal acute radiation syndrome (GI-ARS).The program is expected to support Tivic's development strategy for Entolimod™ as a medical countermeasure for acute radiation syndrome (AR
TIVC FAQ
6 questionsWhat does Tivic Health Systems Inc. do?
Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. The company's primary product, ClearUP, is a medical device intended to relieve sinus and nasal inflammation. It sells its products on direct-to-consumer channel through its own websites and platforms, such as Amazon.com, as well as to major U.S. online retailers, such as BestBuy.com, FSAStore.com, Walgreens.com, Walmart.com. The company was incorporated in 2016 and is headquartered in Newark, California.Where does TIVC stock trade?
Tivic Health Systems Inc. (TIVC) is listed on NASDAQ.What sector and industry is TIVC in?
Tivic Health Systems Inc. operates in the Health Care sector, Biotechnology: Electromedical & Electrotherapeutic Apparatus industry.When did Tivic Health Systems Inc. go public?
Tivic Health Systems Inc. (TIVC) completed its IPO in 2021.What companies are similar to TIVC?
Notable peers in the same industry include MDT (Medtronic plc.), MASI (Masimo Corporation), SEAS (SeaWorld Entertainment Inc.), LIVN (LivaNova PLC), ITGR (Integer Holdings Corporation). Compare TIVC side-by-side with any of them on Quantisnow.How can I track TIVC on Quantisnow?
Quantisnow aggregates Tivic Health Systems Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TIVC to receive live email and push alerts on every new disclosure.